Capricor Therapeutics
Price & Volume
Stats
See more52W Range | $3.84-$23.40 |
Market Cap | $367.4M |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $17.3M |
Revenue Growth (YoY) | -7.9% |
Gross Profit (12 Mos) | -$40.4M |
Diluted EPS | -$1.37 |
News
See moreYahoo Finance • yesterday
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Capricor Therapeutics
Yahoo Finance • 2 days ago
Bragar Eagel & Squire, P.C. Urges Investors in XPLR Infrastructure, Centene, Biohaven, or Capricor to Inquire About Their Rights in Class Action Lawsuits
Yahoo Finance • 2 days ago
Levi & Korsinsky Reminds Capricor Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 15, 2025 – CAPR
Yahoo Finance • 2 days ago
Stock market today: S&P 500 slips as Trump extends China tariff deadline
About
CEO | Dr. Linda Marbán Ph.D. |
CFO | Mr. Anthony J. Bergmann M.B.A. |
Address | 10865 Road to the Cure, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 160 |
